• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症阴性症状的临床表现、发病机制及心理测量评估

Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.

作者信息

Wójciak Paweł, Rybakowski Janusz

机构信息

Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego w Poznaniu.

出版信息

Psychiatr Pol. 2018 Apr 30;52(2):185-197. doi: 10.12740/PP/70610.

DOI:10.12740/PP/70610
PMID:29975360
Abstract

Negative symptoms of schizophrenia constitute a serious diagnostic and therapeutic problem. They substantially account for the impairment of health, social functioning and quality of life whereas treatment is difficult. In this paper the development of the concept of schizophrenia and negative symptoms is presented. The models of positive and negative symptoms, introduced in the 1980's by Timothy Crow and Nancy Andreasen, and William Carpenter's concept of so-called deficit syndrome with the criteria of the division of negative symptoms into the primary and secondary, are discussed. Current views on the pathogenesis of negative symptoms are shown with reference to neuroimaging studies, neurotransmitter alterations, neuropsychological deficits, genetic, immunological and epidemiological studies. A subsection is devoted to the diagnostics tools for negative symptoms. Chronologically, they are divided into scales of the 1st and 2nd generation. The first generation includes: the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS), the Positive and Negative Syndrome Scale (PANSS), the Schedule for the Deficit Syndrome (SDS), and the Proxy for Deficit Syndrome. The second generation scales, developed as a result of the recommendation by American experts in 2006, include: the Brief Negative Syndrome Scale (BNSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS), also the self-assessment scales: the Motivation and Pleasure Scale - Self Report (MAP-SR) and the Self-assessment of Negative Symptoms (SNS). The BNSS and the SNS scales, whose Polish versions were elaborated in the Department of Adult Psychiatry of Poznan University of Medical Sciences, are discussed in-depth.

摘要

精神分裂症的阴性症状构成了一个严重的诊断和治疗难题。它们在很大程度上导致了健康受损、社会功能障碍和生活质量下降,而治疗却很困难。本文介绍了精神分裂症及阴性症状概念的发展历程。文中讨论了由蒂莫西·克劳和南希·安德烈亚森于20世纪80年代提出的阳性和阴性症状模型,以及威廉·卡彭特提出的所谓缺陷综合征概念,该概念将阴性症状分为原发性和继发性的标准。文中还结合神经影像学研究、神经递质改变、神经心理学缺陷、遗传学、免疫学和流行病学研究,展示了目前对阴性症状发病机制的观点。有一个小节专门讨论阴性症状的诊断工具。按时间顺序,它们分为第一代和第二代量表。第一代包括:简明精神病评定量表(BPRS)、阴性症状评定量表(SANS)、阳性和阴性症状量表(PANSS)、缺陷综合征评定量表(SDS)以及缺陷综合征替代量表。第二代量表是根据美国专家2006年的建议制定的,包括:简明阴性症状量表(BNSS)和阴性症状临床评估访谈(CAINS),还有自我评估量表:动机与愉悦量表 - 自我报告(MAP-SR)和阴性症状自我评估量表(SNS)。文中深入讨论了由波兹南医科大学成人精神病学系精心编制波兰语版本的BNSS和SNS量表。

相似文献

1
Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.精神分裂症阴性症状的临床表现、发病机制及心理测量评估
Psychiatr Pol. 2018 Apr 30;52(2):185-197. doi: 10.12740/PP/70610.
2
The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.阴性症状临床评估访谈(CAINS):最终的开发和验证。
Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.
3
Tools to assess negative symptoms in schizophrenia.评估精神分裂症阴性症状的工具。
J Clin Psychiatry. 2013 Jun;74(6):e12. doi: 10.4088/JCP.12045tx2c.
4
Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.动机与愉悦量表-自我报告(MAP-SR):用于筛查精神分裂症阴性症状的自我报告测量工具德文版的验证
Compr Psychiatry. 2016 Feb;65:110-5. doi: 10.1016/j.comppsych.2015.11.001. Epub 2015 Nov 17.
5
[Scale for assessing negative symptoms in schizophrenia: A systematic review].[精神分裂症阴性症状评估量表:系统评价]
Encephale. 2016 Apr;42(2):165-71. doi: 10.1016/j.encep.2015.12.020. Epub 2016 Feb 26.
6
Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.评估精神分裂症的阴性症状:新加坡阴性症状临床评估访谈的有效性。
Schizophr Res. 2019 Apr;206:177-182. doi: 10.1016/j.schres.2018.11.029. Epub 2018 Dec 14.
7
Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).阴性症状临床评估量表(CAINS)西班牙语版本的验证
Schizophr Res. 2015 Aug;166(1-3):104-9. doi: 10.1016/j.schres.2015.06.006. Epub 2015 Jun 23.
8
Psychometric evaluation of the negative syndrome of schizophrenia.精神分裂症阴性症状的心理测量评估。
Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):559-66. doi: 10.1007/s00406-015-0595-z. Epub 2015 Mar 24.
9
Polish version of the Self-evaluation of Negative Symptoms (SNS).阴性症状自评量表(SNS)波兰语版本。
Psychiatr Pol. 2019 Jun 30;53(3):551-559. doi: 10.12740/PP/OnlineFirst/97352.
10
Validation of the Danish version of the brief negative symptom scale.丹麦版简明阴性症状量表的验证
Nord J Psychiatry. 2019 Oct;73(7):425-432. doi: 10.1080/08039488.2019.1648549. Epub 2019 Aug 13.

引用本文的文献

1
Nursing care of a patient with negative symptoms of schizophrenia who underwent tracheotomy: A case report.1例接受气管切开术的精神分裂症阴性症状患者的护理:病例报告
World J Clin Cases. 2025 Sep 6;13(25):108124. doi: 10.12998/wjcc.v13.i25.108124.
2
Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS).氯氮平抵抗性精神分裂症(CRS)患者的磁休克治疗(MST)优化治疗
Neuropsychiatr Dis Treat. 2025 Mar 5;21:491-501. doi: 10.2147/NDT.S497725. eCollection 2025.
3
Dissociative psychosis or dissociative schizophrenia? Comparison of two phenomena.
分离性精神病还是分离性精神分裂症?两种现象的比较。
BMC Psychiatry. 2025 Jan 21;25(1):62. doi: 10.1186/s12888-025-06477-0.
4
A New Three-Hit Mouse Model of Neurodevelopmental Disorder with Cognitive Impairments and Persistent Sociability Deficits.一种具有认知障碍和持续性社交能力缺陷的神经发育障碍新三打击小鼠模型。
Brain Sci. 2024 Dec 20;14(12):1281. doi: 10.3390/brainsci14121281.
5
Correlations of cognitive function with serum levels of homocysteine, sex hormone binding globulin, and leptin in patients with schizophrenia.精神分裂症患者认知功能与血清同型半胱氨酸、性激素结合球蛋白及瘦素水平的相关性
Pak J Med Sci. 2024 Nov;40(10):2319-2323. doi: 10.12669/pjms.40.10.8923.
6
Shen-based Qigong Exercise improves cognitive impairment in stable schizophrenia patients in rehabilitation wards: a randomized controlled study.基于神的气功锻炼改善康复病房稳定精神分裂症患者的认知障碍:一项随机对照研究。
BMC Psychiatry. 2024 Nov 13;24(1):796. doi: 10.1186/s12888-024-06146-8.
7
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy.COMT 和 Neuregulin 1 标志物可用于预测利培酮单药治疗精神分裂症谱系障碍的个体化疗效。
Biomolecules. 2024 Jun 29;14(7):777. doi: 10.3390/biom14070777.
8
Relationship of sociodemographic and clinical characteristics to mechanical restraint used in a psychiatric hospital in Spain.西班牙一家精神病医院社会人口学和临床特征与机械约束使用之间的关系。
J Adv Nurs. 2025 Mar;81(3):1300-1311. doi: 10.1111/jan.16305. Epub 2024 Jul 24.
9
Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment.精神分裂症患者的认知:工作记忆、紊乱症状、解离与精神病发作及病程之间的相互作用,以及对治疗的抵抗性
Biomedicines. 2023 Nov 22;11(12):3114. doi: 10.3390/biomedicines11123114.
10
Validity and reliability of a Chinese version of the self-evaluation of negative symptoms.中文版自我负性症状评估的有效性和可靠性。
Brain Behav. 2023 Apr;13(4):e2924. doi: 10.1002/brb3.2924. Epub 2023 Mar 13.